Biose Industries takes pride in showcasing its partners and drawing attention to the fantastic work they are doing. We sat down with Alveolus Bio with whom we are working to bring their inhalable live biotherapeutic (LBP) to market. Read on to understand the challenges in developing an LBP for lung indications, the origins of Alveolus’...
The Pharmabiotics Conference & Partnering returned for 2023, bringing together cutting-edge microbiome researchers and drug developers. In the heart of Lyon 220 microbiome stakeholders gathered to explore key topics facing the field: from regulatory hurdles to considerations for spinning out. The event featured three panel discussions on developing a drug from “concept to consortia”, the...
Access the Presentation Slides Here
Aurillac, France, March 2nd, 2023 Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, announced today their plan to open a laboratory in the heart of Boston, Massachusetts, later this year. Following Biose Industries overwhelming success in LBP process development and manufacturing throughout...
L-GAM and the French State through the “French Tech Souveraineté” scheme have signed a purchase agreement with the aim of acquiring joint control of Biose Industrie, a world leader in the development and production of Live Biotherapeutic Products (LBPs), in order to support the group in a new phase of its development. Biose Industrie is...
Introduction Kisaco Research’s flagship Microbiome Connect event returned to Boston in November. Joined by a range of microbiome companies and researchers, the event covered both the R&D and manufacturing considerations for microbiome drug development. From freeze-drying techniques for LBP development to synthetic therapeutic approaches, the conference platformed a diverse topic roster. Some highlights of...
The vaginal microbiota plays a key role in regulating vaginal health. Unlike other human microbiomes where bacterial diversity is positive, a healthy vaginal microbiota is associated with Lactobacillus species dominance. Lactobacillus spp. maintain vaginal community composition through lactic acid production and epithelial binding, protecting the host from pathogenic species. In 2002 the first study using...
Within the body’s renal system, the kidneys are the main players. Each person’s kidneys manage to filter around 200 litres of fluid per day, working to remove toxins from the blood, balance electrolytes, keep a consistent amount of water in the body, and secrete essential hormones. In the past decade, scientists have looked at how...
The Microbiome Connect Europe event, by Kisaco Research, was held recently in Amsterdam, the Netherlands. The speakers covered many facets of microbiome-focused products: discovery, clinical validation and mechanisms of action, commercial development, and manufacturing. Despite several high-profile microbiome companies facing closure during the past year, the industry remains strong—the conference showcased many diverse and promising...
Established since 1951, we provide a full range of services as a CDMO for Live Biotherapeutic Products (LPBs).
